Confer Aw

496 citations
21 papers · 434 indexed · h-index 13
Partner nations
United States

In The Last Decade

Confer Aw

21 papers receiving 411 citations

Peers

Confer Aw
Comparison fields: 5 of 48
  • Microbiology 355
  • Virology 82
  • Parasitology 77
  • Endocrinology 39
  • Small Animals 47
Replace Toyotsugu NAKAI with:
Toyotsugu NAKAI Japan
Frank Gh United States
F. A. Lainson United Kingdom
L. A. Page United States
T. Yagihashi Japan
P A Doig Canada
Jennifer Conlon Canada
Søren Rosendal Canada
G.E. Jones United Kingdom
W. E. Bailie United States
Confer Aw relative to Toyotsugu NAKAI Japan Toyotsugu NAKAI's profile →
Citations per field
00.5×10×13×
Toyotsugu NAKAI · 1×
Citations per year

Countries citing papers authored by Confer Aw

Since Specialization
Citations

This map shows the geographic impact of Confer Aw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Confer Aw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Confer Aw more than expected).

Fields of papers citing papers by Confer Aw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Confer Aw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Confer Aw. The network helps show where Confer Aw may publish in the future.

Co-authorship network

The 3 scholars most cited alongside Confer Aw, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Confer Aw Line = papers co-authored together Confer Aw links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1
In vivo effect of Pasteurella haemolytica infection on bovine neutrophil morphology.
199813
2
Vaccination of cattle with outer membrane protein-enriched fractions of Pasteurella haemolytica and resistance against experimental challenge exposure.
199535
3
Sequential development of antigens and toxins of Pasteurella haemolytica serotype 1 grown in cell culture medium.
199210
4
Comparison of antibody responses in cattle to outer membrane proteins from Pasteurella haemolytica serotype 1 and from eight untypeable strains.
199211
5
Comparison of antigens of Pasteurella haemolytica serotype 1 grown in vitro and in vivo.
19925
6
Direct effects of Pasteurella haemolytica lipopolysaccharide on bovine pulmonary endothelial cells in vitro.
198930
7
Effects of Pasteurella haemolytica leukotoxin on cultured bovine lymphoma cells.
198946
8
Serum antibody response to carbohydrate antigens of Pasteurella haemolytica serotype 1: relation to experimentally induced bovine pneumonic pasteurellosis.
198937
9
Brucella abortus-specific immunoglobulin in isotypes in serum and vaginal mucus from cattle vaccinated with strain 19 and challenge exposed with virulent strain 2308.
19884
10
Immunologic response to Pasteurella haemolytica and resistance against experimental bovine pneumonic pasteurellosis, induced by bacterins in oil adjuvants.
198732
11
Chromatographic separation and characterization of Pasteurella haemolytica cytotoxin.
198617
12
Effects of Pasteurella haemolytica lipopolysaccharide on selected functions of bovine leukocytes.
198641
13
Serum antibodies to Pasteurella haemolytica lipopolysaccharide: relationship to experimental bovine pneumonic pasteurellosis.
198636
14
Comparison of the antigens associated with saline solution, potassium thiocyanate, and sodium salicylate extracts of Pasteurella haemolytica serotype 1.
198611
15
Immunologic response and resistance to experimentally induced pneumonic pasteurellosis in cattle vaccinated with various dosages of lyophilized Pasteurella haemolytica.
198613
16
Transient enhancement of the serum antibody response to Brucella abortus strain 19 in cattle treated with levamisole.
19854
17
Bovine pneumonic pasteurellosis: effect of culture age of Pasteurella haemolytica used as a live vaccine.
198421
18
Effect of prior natural exposure to Pasteurella haemolytica on resistance to experimental bovine pneumonic pasteurellosis.
198420
19
Sequential mitogen stimulation of peripheral blood lymphocytes from chickens inoculated with infectious bursal disease virus.
198137
20
Disseminated nocardiosis in an Arabian foal.
19813

About Confer Aw

Confer Aw is a scholar working on Microbiology, Microbiology and Virology, having authored 21 papers that have together received 434 indexed citations. Recurring topics across this work include Microbial infections and disease research (17 papers), Toxoplasma gondii Research Studies (5 papers), Veterinary Oncology Research (5 papers), Animal Virus Infections Studies (5 papers), Virus-based gene therapy research (4 papers), Rabies epidemiology and control (4 papers), Toxin Mechanisms and Immunotoxins (4 papers) and Bacteriophages and microbial interactions (2 papers). The work is most often cited by research in Microbiology (355 citations), Virology (82 citations) and Parasitology (77 citations). Confer Aw has collaborated with scholars based in United States. Frequent co-authors include Ewing Sa, Frank Gh and Karan Pandher. Their work appears in journals such as American Journal of Veterinary Research and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026